Cargando…
Single-center experience of patients with interstitial lung diseases during the early days of the COVID-19 pandemic
INTRODUCTION: Patients with interstitial lung diseases (ILD) can be suspected to be at risk of experiencing a rapid flare-up due to COVID-19. However, no specific data are currently available for these patients. METHODS: We retrospectively analyzed a cohort of 401 patients with ILD and determined th...
Autores principales: | Guiot, J., Henket, M., Frix, A.N., Delvaux, M., Denis, A., Giltay, L., Thys, M., Gester, F., Moutschen, M., Corhay, J.L., Louis, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Respiratory Society. Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501770/ https://www.ncbi.nlm.nih.gov/pubmed/32978099 http://dx.doi.org/10.1016/j.resinv.2020.08.006 |
Ejemplares similares
-
Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype ?
por: Guiot, Julien, et al.
Publicado: (2022) -
Progressive fibrosing interstitial lung disease in rheumatoid arthritis: A retrospective study
por: Denis, Anna, et al.
Publicado: (2022) -
Airflow obstruction as a marker of adverse prognosis in rheumatoid arthritis
por: Guiot, Julien, et al.
Publicado: (2023) -
Could KL-6 levels in COVID-19 help to predict lung disease?
por: Frix, AN, et al.
Publicado: (2020) -
Sputum biomarkers in IPF: Evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7
por: Guiot, J., et al.
Publicado: (2017)